Literature DB >> 7435141

Tumorigenic cell culture lines from a spontaneous VM/Dk murine astrocytoma (SMA).

R D Serano, C N Pegram, D D Bigner.   

Abstract

One of the few spontaneous gliomas in inbred animals, the VM/Dk spontaneous murine astrocytoma (SMA), has seen limited use. Previously restricted to an in vivo system, the SMA was only transplantable intracerebrally (IC) using nonquantifiable suspensions of normal brain and tumor tissue. Prior attempts at establishing permanent tumorigenic SMA cell lines have not succeeded; tumorigenicity was lost during serial in vitro passage. We have established three different cell culture lines from a serially IC-transplanted SMA and two from tumors that arose from intraperitoneal (IP) injection of the IC-transplanted SMA. In contrast to previous cell cultures and transplantable lines of SMA, all five cell lines are not only tumorigenic IC but subcutaneously (SC) as well. Astrocytic feature are present in three of five lines to varying degrees, evidenced by in vitro and in vivo morphology, response to dibutyryl cyclic AMP (db-cAMP), and the presence of neuroglial fibers: None of the lines express CNPase, S-100, or GFA proteins in significant amounts. P560, highly tumorigenic and possessing the most astrocytic features of the five lines, extends the use of the spontaneous astrocytoma system of the inbred VM/Dk mouse strain by allowing quantitative in vivo and in vitro experiments.

Entities:  

Mesh:

Year:  1980        PMID: 7435141     DOI: 10.1007/bf00688850

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  29 in total

1.  Quantitative aspects of transplacental tumor induction with ethylnitrosourea in rats.

Authors:  J A Swenberg; A Koestner; W Wechsler; R H Denlinger
Journal:  Cancer Res       Date:  1972-12       Impact factor: 12.701

2.  2',3'-cyclic nucleotide 3'-phosphohydrolase in brains of mutant mice with deficient myelination.

Authors:  T Kurihara; J L Nussbaum; P Mandel
Journal:  J Neurochem       Date:  1970-07       Impact factor: 5.372

3.  In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.

Authors:  M Jurin; H D Suit
Journal:  Cancer Res       Date:  1972-10       Impact factor: 12.701

4.  Appearance of a brain specific antigen (th S-100 protein) during human foetal development.

Authors:  J E Zuckerman; H R Herschman; L Levine
Journal:  J Neurochem       Date:  1970-02       Impact factor: 5.372

5.  Astrocytomas in an inbred mouse strain.

Authors:  H Fraser
Journal:  J Pathol       Date:  1971-04       Impact factor: 7.996

6.  Therapy in an intracerebral murine glioma model, using Bacillus Calmette-Guérin, neuraminidase-treated tumor cells, and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.

Authors:  L Albright; J C Madigan; M R Gaston; D P Houchens
Journal:  Cancer Res       Date:  1975-03       Impact factor: 12.701

7.  An experimental mouse testicular teratoma as a model for neuroepithelial neoplasia and differentiation. II. Electron microscopy.

Authors:  M M Herman; J C Sipe; L J Rubinstein; S R Vandenberg; A M Spence; J Vraa-Jensen
Journal:  Am J Pathol       Date:  1975-11       Impact factor: 4.307

8.  Cellular heterogeneity in an ethylnitrosourea-induced glioma: malignancy, karyology and other properties of tumour cell types.

Authors:  P J Claisse; J P Roscoe; P L Lantos
Journal:  Br J Exp Pathol       Date:  1979-04

Review 9.  Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution.

Authors:  G Klein; E Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

10.  A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.

Authors:  H B Hewitt; E R Blake; A S Walder
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

View more
  20 in total

1.  The VM model of glioma: preparation of multicellular tumour spheroids (MTS) and their response to chemotherapy.

Authors:  R Bradford; J L Darling; N Sier; D G Thomas
Journal:  J Neurooncol       Date:  1990-10       Impact factor: 4.130

2.  EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss.

Authors:  John H Sampson; Bryan D Choi; Luis Sanchez-Perez; Carter M Suryadevara; David J Snyder; Catherine T Flores; Robert J Schmittling; Smita K Nair; Elizabeth A Reap; Pamela K Norberg; James E Herndon; Chien-Tsun Kuan; Richard A Morgan; Steven A Rosenberg; Laura A Johnson
Journal:  Clin Cancer Res       Date:  2013-12-18       Impact factor: 12.531

3.  The in-vitro chemosensitivity of three cell lines derived from the VM/DK spontaneous murine astrocytoma.

Authors:  R Bradford; J L Darling; D G Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-12       Impact factor: 10.154

4.  T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma.

Authors:  Karolina Woroniecka; Pakawat Chongsathidkiet; Kristen Rhodin; Hanna Kemeny; Cosette Dechant; S Harrison Farber; Aladine A Elsamadicy; Xiuyu Cui; Shohei Koyama; Christina Jackson; Landon J Hansen; Tanner M Johanns; Luis Sanchez-Perez; Vidyalakshmi Chandramohan; Yen-Rei Andrea Yu; Darell D Bigner; Amber Giles; Patrick Healy; Glenn Dranoff; Kent J Weinhold; Gavin P Dunn; Peter E Fecci
Journal:  Clin Cancer Res       Date:  2018-02-07       Impact factor: 12.531

Review 5.  Vaccine-based immunotherapeutic approaches to gliomas and beyond.

Authors:  Michael Weller; Patrick Roth; Matthias Preusser; Wolfgang Wick; David A Reardon; Michael Platten; John H Sampson
Journal:  Nat Rev Neurol       Date:  2017-05-12       Impact factor: 42.937

6.  Genetic analysis of intracranial tumors in a murine model of glioma demonstrate a shift in gene expression in response to host immunity.

Authors:  Chris A Learn; Peter M Grossi; Robert J Schmittling; Weihua Xie; Duane A Mitchell; Isaac Karikari; ZhengZheng Wei; Holly Dressman; John H Sampson
Journal:  J Neuroimmunol       Date:  2006-11-29       Impact factor: 3.478

7.  Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma.

Authors:  R Chambers; G Y Gillespie; L Soroceanu; S Andreansky; S Chatterjee; J Chou; B Roizman; R J Whitley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

Review 8.  Harnessing preclinical mouse models to inform human clinical cancer trials.

Authors:  David H Gutmann; Kim Hunter-Schaedle; Kevin M Shannon
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

9.  Lysosomal ceramide mediates gemcitabine-induced death of glioma cells.

Authors:  Claudia A Dumitru; Ibrahim E Sandalcioglu; Marek Wagner; Michael Weller; Erich Gulbins
Journal:  J Mol Med (Berl)       Date:  2009-09-10       Impact factor: 4.599

10.  Proteomic and immunologic analyses of brain tumor exosomes.

Authors:  Michael W Graner; Oscar Alzate; Angelika M Dechkovskaia; Jack D Keene; John H Sampson; Duane A Mitchell; Darell D Bigner
Journal:  FASEB J       Date:  2008-12-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.